A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension
Anne L Coleman, Fabian Lerner, Paula Bernstein, Scott M WhitcupVolume:
110
Year:
2003
Language:
english
DOI:
10.1016/s0161-6420(03)00662-6
File:
PDF, 157 KB
english, 2003